Revolade, known generically as eltrombopag, is a medication primarily used to treat certain blood disorders, including chronic immune thrombocytopenia (ITP), a condition where the immune system attacks and destroys platelets, leading to a low platelet count and increased risk of bleeding. It is also used in patients with hepatitis C to enable the use of interferon-based therapies and for the treatment of severe aplastic anemia, a rare disease in which the bone marrow fails to produce enough new blood cells. Revolade works by stimulating the bone marrow to produce more platelets, thereby helping to prevent bleeding episodes. It is available in tablet form and is taken orally. As with any medication, it is important to use Revolade under the guidance of a healthcare professional to ensure its safe and effective use.